Issue 1, 2011

An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance

Abstract

Synthetic riboswitch containing aptamer is constructed in E. coli to regulate the expression of β-lactamase through small molecule–aptamer interactions, which sharply reduces the antibiotic resistance of the engineered bacteria.

Graphical abstract: An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance

Supplementary files

Article information

Article type
Communication
Submitted
16 Apr 2010
Accepted
02 Jun 2010
First published
30 Jun 2010

Chem. Commun., 2011,47, 173-175

An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance

X. Feng, L. Liu, X. Duan and S. Wang, Chem. Commun., 2011, 47, 173 DOI: 10.1039/C0CC00980F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements